TCIM
MGNX icon

TIAA CREF Investment Management’s MacroGenics MGNX Stock Holding History

TIAA CREF Investment Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.67M Sell
148,387
-14,869
-9% -$257K ﹤0.01% 1833
2018
Q4 		$2.07M Sell
163,256
-1,578
-1% -$26.5K ﹤0.01% 1935
2018
Q3 		$3.53M Sell
164,834
-5,969
-3% -$127K ﹤0.01% 1813
2018
Q2 		$3.53M Buy
170,803
+88,583
+108% +$2M ﹤0.01% 1849
2018
Q1 		$2.07M Buy
82,220
+2,054
+3% +$49.9K ﹤0.01% 2079
2017
Q4 		$1.52M Sell
80,166
-9,046
-10% -$169K ﹤0.01% 2272
2017
Q3 		$1.65M Buy
89,212
+913
+1% +$15.8K ﹤0.01% 2269
2017
Q2 		$1.55M Buy
88,299
+1,859
+2% +$35.5K ﹤0.01% 2335
2017
Q1 		$1.61M Sell
86,440
-4,101
-5% -$79.1K ﹤0.01% 2261
2016
Q4 		$1.85M Sell
90,541
-8,986
-9% -$226K ﹤0.01% 2231
2016
Q3 		$2.98K Buy
99,527
+257
+0.3% +$7.64K ﹤0.01% 1940
2016
Q2 		$2.68M Buy
99,270
+5,155
+5% +$116K ﹤0.01% 1945
2016
Q1 		$1.76M Sell
94,115
-11,859
-11% -$226K ﹤0.01% 2150
2015
Q4 		$3.28M Sell
105,974
-13,658
-11% -$415K ﹤0.01% 1836
2015
Q3 		$2.56M Buy
119,632
+3,099
+3% +$97.2K ﹤0.01% 1996
2015
Q2 		$4.42M Buy
116,533
+16,489
+16% +$542K ﹤0.01% 1784
2015
Q1 		$3.14M Buy
100,044
+16,027
+19% +$543K ﹤0.01% 1940
2014
Q4 		$2.95M Buy
84,017
+4,351
+5% +$108K ﹤0.01% 1986
2014
Q3 		$1.67M Buy
79,666
+5,015
+7% +$104K ﹤0.01% 2343
2014
Q2 		$1.62M Buy
74,651
+51,180
+218% +$1.08M ﹤0.01% 2426
2014
Q1 		$653K Buy
23,471
+8,340
+55% +$294K ﹤0.01% 2860
2013
Q4 		$415K Buy
+15,131
New +$396K ﹤0.01% 3005

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TIAA CREF Investment Management's MGNX Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its MacroGenics (MGNX) stake by 9.1% in Q1 2019, selling an estimated $257K and leaving 148,387 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

TIAA CREF Investment Management first reported a position in MGNX in Q4 2013 and has held it in 22 quarters since. The position peaked at $4.42M in Q2 2015. 157 funds tracked by Wall St. Rank hold MGNX as of Q1 2019.

  • TIAA CREF Investment Management held 148,387 shares of MacroGenics worth $2.67M as of Q1 2019.
  • TIAA CREF Investment Management sold 14,869 MacroGenics shares in Q1 2019, an estimated $257K.
  • MacroGenics made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1833 holding.
  • TIAA CREF Investment Management first reported a position in MacroGenics in Q4 2013 and has held it in 22 quarters since.
  • TIAA CREF Investment Management's MacroGenics position peaked at $4.42M in Q2 2015.
  • 157 funds tracked by Wall St. Rank held MacroGenics as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.